Cortical Activation Changes in Hirayama Disease After Anterior Cervical Decompression and Fusion

Hong-Li Wang1, Yi-Wei Wu2, Jian Song1

  • 1Department of Orthopedics, Huashan Hospital, Fudan University, Shanghai, China.

World Neurosurgery
|May 20, 2018
PubMed

Insights

Hirayama disease (HD) surgery improved grip strength and altered brain activity. Postoperative recovery in HD involves reduced motor cortex activation, indicating functional brain changes.

Area of Science:

  • Neuroscience
  • Neurosurgery
  • Rehabilitation Medicine

Background:

  • Hirayama disease (HD) can lead to spinal cord changes.
  • Cortical reorganization is a known response to spinal cord injury.
  • Investigating cortical activation changes after surgery in HD is crucial.

Purpose of the Study:

  • To explore cortical activation changes before and after anterior cervical decompression and fusion surgery in patients with Hirayama disease (HD).
  • To correlate functional magnetic resonance imaging (fMRI) findings with grip strength improvements post-surgery.

Main Methods:

  • 17 HD patients underwent anterior cervical decompression and fusion surgery.
  • fMRI scans were conducted preoperatively and at 3 months, 6 months, and 1 year post-surgery.
  • Grip strength was measured, and fMRI data were analyzed for primary motor area (M1) activation in both hands.

Main Results:

  • Grip strength significantly improved in both symptomatic and asymptomatic hands post-surgery, peaking at 6 months.
  • Preoperatively, symptomatic hand tasks showed stronger bilateral (ipsilateral and contralateral) M1 activation.
  • Post-surgery, both ipsilateral and contralateral M1 activation in symptomatic hand tasks decreased, becoming significant by 6 months.

Conclusions:

  • Anterior cervical decompression and fusion surgery in HD patients is associated with changes in primary motor cortex (M1) activation.
  • Functional recovery in the symptomatic limb correlates with reduced M1 activation (both ipsilateral and contralateral).
  • Postoperative cortical activation patterns may serve as indicators of functional recovery in Hirayama disease.
Abstract

Related Concept Videos

Nuclear Fusion02:45

Nuclear Fusion

The process of converting very light nuclei into heavier nuclei is also accompanied by the conversion of mass into large amounts of energy, a process called fusion. The principal source of energy in the sun is a net fusion reaction in which four hydrogen nuclei fuse and ultimately produce one helium nucleus and two positrons.
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
33.9K
Muscles of the Anterior Neck01:26

Muscles of the Anterior Neck

The anterior neck muscles are the group of muscles covering the front part of the neck. These muscles are classified into three subgroups. The first one is the superficial muscles, the most visible muscles in the front of the neck. It includes the platysma and sternocleidomastoid. The second group is the suprahyoid muscles, located above the hyoid bone. This group comprises the digastric, mylohyoid, geniohyoid, and stylohyoid. Lastly, the infrahyoid muscles are found below the hyoid bone and...
4.9K
Tagging and Fusion Proteins01:24

Tagging and Fusion Proteins

Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
8.5K
SNAREs and Membrane Fusion01:43

SNAREs and Membrane Fusion

Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
12.9K
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
234
Fusion of Secretory Vesicles with the Plasma Membrane01:26

Fusion of Secretory Vesicles with the Plasma Membrane

Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
19.0K